Management of COPD

References

• Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 1993; 328(14):1017–22
   PubMed Web of Science ®Google Scholar
• Celli BR, Snider GL, Heffner J, et al for the American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am] Respir Crit Care Med 1995; 152(5 Pt2):S77–121
   Google Scholar
• Siafakas NM, Vermeire P, Pride NB, et al for the European Respiratory Society Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8(8):1398–420
   PubMed Web of Science ®Google Scholar
• Higgins MW. Epidemiology of obstructive pulmonary disease. In: Casaburi R, Petty TL, eds. Principles and practice of pulmonary rehabilitation. Philadelphia: Saunders, 1993: 10–17
   Google Scholar
• Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317(21):1309–14
   PubMed Web of Science ®Google Scholar
• Campbell AH, Barter CE, O'Connell JM, et al. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax 1985; 40(10):741–8
   Google Scholar
• Sandford AJ, Weir TD, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 1997; 10(6): 1380–91
   Google Scholar
• Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994; 272(19):1497–505
   PubMed Web of Science ®Google Scholar
• Smoking Cessation Clinical Practice Guideline Panel and Staff. The Agency for Health Care Policy and Research smoking cessation clinical practice guideline. JAMA 1996; 275(16): 1270–80
   Google Scholar
• Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337(17):1195–202
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Lofdahl CG, Pride NB, et al. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (EUROSCOP): hypothesis and design. Eur Respir J 1992; 5(10):1254–61
   Google Scholar
• Wewers MD, Casolaro MA, Sellers SE, et al. Replacement therapy for alpha1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987; 316(17):1055–62
   PubMed Web of Science ®Google Scholar
• Gadek JE. Alpha1-antitrypsin: a world view. Chest 1996; 110(Suppl):237-94S
   Google Scholar
• Britton JR, Pavord ID, Richards KA, et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995; 151(5):1383–7
   PubMed Web of Science ®Google Scholar
• Skorodin MS. Pharmacotherapy for asthma and chronic obstructive pulmonary disease: current thinking, practices, and controversies. Arch Intern Med 1993; 153(7):814–28
   Google Scholar
• Ziment I. Pharmacologic therapy of obstructive airway disease. Clin Chest Med 1990; 11(3):461–86
   PubMedGoogle Scholar
• Gross NJ, Petty TL, Friedman M, et al. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease: a three-center study. Am Rev Respir Dis 1989; 139(5):1188–91
   PubMed Web of Science ®Google Scholar
• Coughlin SS, Metayer C, McCarthy EP, et al. Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study. Am J Epidemiol 1995; 142(4):395–403
   Google Scholar
• Murciano D, Auclair MH, Pariente R, et al. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med 1989; 320(23):1521–5
   PubMed Web of Science ®Google Scholar
• Martin RJ, Pak J. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145(3):540–4
   Google Scholar
• COMB1VENT Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: an 85-day multicenter trial. Chest 1994; 105(5):1411–9
   Google Scholar
• Thomas P, Pugsley JA, Stewart JH. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease. Chest 1992; 101 (1): 160–5
   Google Scholar
• Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991; 114(3):216–23
   PubMed Web of Science ®Google Scholar
• Weir DC, Gove RI, Robertson AS, et al. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990; 45(2):112–7
   PubMed Web of Science ®Google Scholar
• Boman G, Bäcker U, Larsson S, et al. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 1983; 64(6):405–15
   PubMedGoogle Scholar
• Anthonisen NR, Manfreda J, Warren CW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196–204
   PubMed Web of Science ®Google Scholar
• Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146(4):1067–83
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325(21):1453–60
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46(RR-8): 1–24
   PubMedGoogle Scholar
• Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med 1995; 333(11):710–4
   Google Scholar
• Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333(13):817–22
   PubMed Web of Science ®Google Scholar
• Light RW, Muro JR, Sato RI, et al. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 139(1):126–33
   PubMedGoogle Scholar
• Celli BR. Pulmonary rehabilitation in patients with COPD. Am J Respir Crit Care Med 1995; 152(3):861–4
   Google Scholar
• Ries AL, Kaplan RM, Limberg TM, et al. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122(11):823–32
   PubMed Web of Science ®Google Scholar